🔎 Trials Near Me

Home › Parkinson's Disease › NCT07543861

A Pilot Study of In-lab Dynamic Standing in Parkinson's Disease

RecruitingPhase 1

Who can join

Ages 50 and older · All sexes

Full eligibility criteria
Inclusion Criteria:

* Diagnosis of Parkinson's Disease

Exclusion Criteria:

* Inability to stand or walk without an assistive device
* History of symptoms in stance that preclude safe and comfortable participation, such as dizziness and lightheadedness, orthostasis, severe symptomatic leg or back musculoskeletal pain, or medication side effects
* Any other history of medical or psychiatric comorbidity, precluding safe participation in the project.
* History of symptomatic cardiovascular or pulmonary disease
* History of active rheumatic arthritis
* History of stroke or other neurologic conditions with significant residual sensorimotor deficits
* History of disabling chronic pain syndrome requiring narcotic analgesics
* Evidence of dementia (Mini Mental State Exam (or Montreal Cognitive Assessment test) \<24 and significant impairment in activities of daily living)
* Venous ulcerative stasis or severe varicosities.
* Pregnancy as determined by urine pregnancy test prior to DXA procedure in women of childbearing potential.

About the study

This research is studying the use of a new type of standing desk in a small number of people to learn about the user experience for people with Parkinson's disease. 12 4-hour sessions will be performed to test the primary hypothesis that dynamic standing improves gait function compared to static standing and control sitting. This study has 2 phases. Phase 1 will be an open-label study and Phase 2 will be an in-lab randomized controlled trial pilot study. This is phase 1 of the study.

What is being tested

Sponsor: University of Michigan · Participants: 5 · Started: May 15, 2026

Contact the study team

Official record on ClinicalTrials.gov — NCT07543861

Locations in the U.S.

MichiganDomino's Farms, Ann Arbor

Conditions

From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.